Cargando…
Exendin-4 enhances the differentiation of Wharton’s jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers
BACKGROUND: Diabetes mellitus is a devastating metabolic disease. Generation of insulin-producing cells (IPCs) from stem cells, especially from Wharton’s jelly mesenchymal stem cells (WJ-MSCs), has sparked much interest recently. Exendin-4 has several beneficial effects on MSCs and β cells. However,...
Autores principales: | Kassem, Dina H., Kamal, Mohamed M., El-Kholy, Abd El-Latif G., El-Mesallamy, Hala O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981957/ https://www.ncbi.nlm.nih.gov/pubmed/27515427 http://dx.doi.org/10.1186/s13287-016-0374-4 |
Ejemplares similares
-
Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
por: Kamal, Mohamed M., et al.
Publicado: (2020) -
Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells into Insulin Producing Cells
por: Ranjbaran, Hossein, et al.
Publicado: (2018) -
Differentiation of Alginate-Encapsulated Wharton Jelly-Derived
Mesenchymal Stem Cells into Insulin Producing Cells
por: Poursafavi, Zahra, et al.
Publicado: (2022) -
The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model
por: El Miniawy, Hala M. F., et al.
Publicado: (2022) -
Cardioprotective Effects of Wharton Jelly Derived Mesenchymal Stem Cell Transplantation in a Rodent Model of Myocardial Injury
por: Gaafar, Taghrid, et al.
Publicado: (2017)